Compounds of formula I ##STR00001## as well as pharmaceutically acceptable salts and esters thereof, wherein R.sup.1, R.sup.2, R.sup.3, A.sup.1 and A.sup.2 have the significance given in claim 1, can be used in the form of pharmaceutical preparations for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity.

 
Web www.patentalert.com

< Pancreatic lipase inhibitor compounds, their synthesis and use

< Treatment of hepatic fibrosis with imatinib mesylate

> Substituted piperidines

> Compounds

~ 00271